clinic
present
sever
acut
respiratori
syndrom
sar
nonspecif
isol
suspect
patient
difficult
limit
avail
isol
facil
studi
chang
haematolog
paramet
sar
patient
use
median
valu
analys
accord
day
symptom
onset
white
cell
wcc
absolut
neutrophil
absolut
lymphocyt
alc
platelet
count
follow
vshape
trend
nadir
day
symptom
onset
except
alc
icu
group
reach
nadir
day
none
patient
platelet
count
l
wcc
l
first
day
symptom
paramet
may
allow
earli
stratif
febril
patient
like
unlik
sar
case
allow
effect
util
isol
facil
multivari
analysi
age
independ
predictor
icu
admiss
global
alert
sever
acut
respiratori
syndrom
sar
issu
world
health
organ
march
one
largest
outbreak
occur
singapor
patient
manag
singl
sarsdesign
hospit
mortal
patient
requir
intens
care
unit
icu
manag
high
lew
et
al
caus
sar
identifi
novel
coronaviru
ksiazek
et
al
peiri
et
al
clinic
case
definit
sar
highli
insensit
highlight
nonspecif
natur
present
symptom
rainer
et
al
although
sequenc
coronaviru
genom
marra
et
al
rota
et
al
allow
develop
specif
diagnost
test
none
fulli
valid
wide
avail
sar
outbreak
tremend
burden
place
hospit
provid
isol
facil
highli
infecti
natur
coronaviru
would
help
routin
laboratori
test
could
help
stratifi
patient
compat
clinic
featur
earli
allow
effici
use
limit
isol
facil
furthermor
earli
identif
patient
poor
prognosi
may
allow
earli
intervent
improv
outcom
larg
cohort
confirm
sar
case
retrospect
analys
haematolog
paramet
aim
describ
chang
paramet
infect
progress
identifi
earli
haematolog
marker
help
exclud
sar
predict
patient
need
icu
admiss
retrospect
review
sar
case
confirm
serolog
test
identif
viral
rna
reversetranscriptas
polymeras
chain
reaction
rtpct
march
may
conduct
follow
patient
exclud
final
analysi
patient
treat
sarsdesign
hospit
patient
year
old
patient
whose
histori
symptom
onset
unclear
studi
approv
hospit
ethic
review
board
patient
divid
two
group
admit
icu
sequenti
result
haematolog
indic
includ
haemoglobin
hb
white
cell
wcc
platelet
absolut
neutrophil
anc
absolut
lymphocyt
count
alc
obtain
patient
tabul
accord
day
ill
day
symptom
onset
design
day
ill
data
collect
includ
demograph
comorbid
condit
chronic
airway
diseas
cardiovascular
diseas
diabet
mellitu
acut
chronic
renal
failur
day
symptom
onset
hospit
admiss
icu
admiss
median
rang
calcul
haematolog
paramet
predictor
icu
admiss
maximum
minimum
valu
whichev
appropri
day
use
potenti
predictor
identifi
use
univari
multivari
logist
regress
analysi
data
analysi
carri
stata
statacorp
lp
colleg
station
tx
usa
level
signific
set
total
confirm
sar
case
met
inclus
criteria
studi
period
requir
icu
manag
characterist
two
group
present
tabl
proport
patient
abnorm
haematolog
indic
differ
stage
infect
present
tabl
wcc
l
wcc
l
wcc
l
polymorph
l
polymorph
l
lymphocyt
l
platelet
l
platelet
l
platelet
l
although
leucopenia
wcc
l
occur
patient
avail
blood
test
day
symptom
onset
respect
sever
neutropenia
anc
l
rare
patient
day
respect
wcc
l
also
rare
affect
patient
occur
day
ill
patient
day
day
develop
moder
lymphopenia
alc
l
point
first
day
ill
howev
sever
lymphopenia
alc
l
rare
occur
patient
day
symptom
respect
reactiv
lymphocyt
commonli
seen
viral
infect
also
conspicu
absent
patient
sar
major
patient
normal
platelet
count
l
patient
never
platelet
count
l
fact
none
patient
test
first
day
ill
platelet
count
l
day
ill
two
patient
test
platelet
count
l
plot
median
valu
haematolog
paramet
period
day
symptom
onset
time
trend
chang
hb
wcc
platelet
count
anc
alc
obtain
figur
hb
group
continu
fall
first
day
ill
graph
shown
wcc
initi
decreas
reach
nadir
day
ill
median
nadir
wcc
l
rang
l
nonicu
l
icu
group
group
chang
anc
reflect
chang
wcc
median
nadir
anc
l
rang
l
nonicu
group
higher
icu
group
l
rang
l
strike
featur
alc
graph
lack
lymphocyt
recoveri
icu
group
nonicu
patient
alc
reach
nadir
day
ill
median
level
l
rang
l
nadir
reach
day
symptom
icu
group
platelet
trend
follow
wcc
anc
platelet
count
reach
nadir
day
ill
nonicu
group
day
ill
icu
group
median
nadir
platelet
count
l
rang
l
l
rang
l
respect
univari
analysi
sex
age
presenc
comorbid
condit
wcc
anc
found
signific
predictor
icu
admiss
tabl
howev
multivari
analysi
age
signific
sar
emerg
infecti
diseas
mani
aspect
pathophysiolog
clinic
behaviour
still
fulli
understood
hamper
progress
diagnosi
effect
manag
one
main
symptom
sar
fever
fever
also
common
viral
infect
includ
dengu
common
asia
possibl
anoth
sar
outbreak
exist
due
highli
infecti
natur
coronaviru
everi
febril
patient
suspect
sar
screen
screen
centr
need
isol
led
high
demand
isol
bed
limit
resourc
acut
care
hospit
sar
outbreak
furthermor
specif
serolog
test
becom
posit
late
cours
diseas
peiri
et
al
whilst
rtpcr
coronaviru
rna
detect
rate
nasopharyng
aspir
plasma
respect
first
day
ill
grant
et
al
poon
et
al
laboratori
featur
first
day
fever
could
suggest
patient
unlik
sar
may
obviat
need
isol
hospit
chose
studi
haematolog
indic
common
laboratori
investig
perform
patient
admit
hospit
fever
blood
count
often
provid
use
clue
regard
diagnosi
complic
infecti
diseas
interest
observ
made
first
day
ill
major
patient
normal
wcc
elev
anc
lymphopenia
normal
hb
platelet
count
period
patient
cohort
moder
lymphopenia
l
although
alc
l
compar
report
figur
lee
et
al
recent
hong
kong
studi
report
patient
moder
lymphopenia
cours
ill
compar
figur
patient
moder
lymphopenia
day
ill
one
notabl
featur
sar
reactiv
lymphocyt
commonli
seen
peripher
blood
film
contrast
common
find
reactiv
lymphocyt
around
fourth
fifth
day
fever
dengu
coincid
recoveri
lymphocyt
count
patient
thisyakorn
et
al
two
hong
kong
studi
report
thrombocytopenia
l
patient
present
patient
cours
ill
respect
wong
et
al
featur
patient
patient
platelet
count
l
day
ill
fact
within
first
day
ill
patient
platelet
count
l
wcc
l
day
two
patient
platelet
count
l
one
patient
preexist
hepatocellular
carcinoma
liver
cirrhosi
sourc
differ
studi
hong
kong
studi
uncertain
may
due
differ
variant
coronaviru
ruan
et
al
exert
differ
effect
patient
differ
treatment
studi
design
contrast
patient
hong
kong
patient
routin
treat
prednisolon
ribavarin
may
affect
platelet
white
cell
count
choi
et
al
analysi
hong
kong
includ
result
patient
even
admit
icu
includ
blood
result
prior
icu
admiss
made
result
reflect
chang
result
coronaviru
infect
affect
treatment
given
absenc
signific
thrombocytopenia
contrast
patient
dengu
commonli
signific
thrombocytopenia
includ
sever
thrombocytopenia
l
first
week
ill
nimmannitya
would
seem
patient
present
sever
thrombocytopenia
l
febril
ill
unlik
sar
appli
patient
present
wcc
l
paramet
may
therefor
help
stratif
febril
patient
suspect
sar
low
highrisk
group
allow
better
alloc
limit
isol
room
avail
wcc
l
l
increas
alc
l
l
increas
platelet
count
l
l
increas
absolut
neutrophil
count
l
increas
haematolog
valu
taken
day
symptom
earli
late
differ
observ
variou
haematolog
paramet
icu
nonicu
group
clear
differ
median
valu
hb
wcc
anc
day
ill
figur
associ
paramet
icu
admiss
test
logist
regress
model
incorpor
paramet
like
age
comorbid
previous
shown
prognost
valu
lee
et
al
univari
analysi
sex
age
presenc
comorbid
condit
wcc
anc
found
signific
predictor
howev
age
remain
signific
multivari
model
recent
hong
kong
studi
also
fail
identifi
haematolog
paramet
predict
icu
admiss
death
multivari
analysi
result
contrast
studi
also
identifi
elev
anc
comorbid
condit
independ
predictor
poor
outcom
howev
studi
may
directli
compar
use
day
ill
onset
basi
data
analysi
rather
day
present
late
differ
day
symptom
onset
includ
greater
increas
wcc
anc
follow
nadir
lack
recoveri
alc
day
ill
icu
group
differ
may
reflect
greater
sever
infect
icu
group
whether
persist
lymphopenia
icu
group
result
inabl
patient
mount
immun
respons
result
seriou
infect
bone
marrow
suppress
caus
viru
unknown
detail
studi
haematolog
chang
one
largest
cohort
sar
patient
manag
singl
institut
strengthen
use
day
ill
basi
data
analysi
compar
day
present
use
previou
studi
lee
et
al
method
remov
confound
effect
caus
variat
day
present
laboratori
measur
taken
everi
day
one
limit
studi
amount
miss
data
could
bia
result
conclus
haematolog
indic
follow
vshape
pattern
sar
except
icu
group
recov
alc
day
symptom
platelet
count
l
wcc
l
encount
sar
patient
first
day
ill
moder
lymphopenia
common
alc
l
uncommon
earli
phase
ill
absenc
reactiv
lymphocyt
anoth
import
featur
distinguish
sar
viral
infect
featur
may
help
earli
stratif
patient
clinic
featur
compat
sar
low
risk
group
possibl
obviat
need
isol
